Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots ...

People who take an anticoagulant medicine double their risk of an internal bleed if they take a type of painkiller called a ...

Maxim Group analyst Naz Rahman has reiterated their bullish stance on TLPH stock, giving a Buy rating on November 14. Naz Rahman has given his ...

Patients with venous thromboembolism (VTE) initiating oral anticoagulants have an increased risk for bleeding when usi ...

Recognized as innovative biopharma developing a potentially safer and superior anticoagulant for patients with implanted cardiac devices and rare cardiovascular conditions PONTE VEDRA, Fla., Nov. 19, ...

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots for patients after heart valve replacement surgery, according to preliminary ...

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots ...

DOACs only and warfarin only are more likely to be prescribed to Medicare beneficiaries seeing clinicians in rural areas compared with urban areas.

The use of anticoagulants offers significant benefits. They are indicated for various uses depending on the specific ...

Assessing when to initiate anticoagulation in atrial fibrillation is not improved by including gender, says the ESC in their ...

Low event rates and short TTRs with warfarin were notable, and questions persist as to which patients truly need OAC.

Patients who receive a heart valve replacement are well-known to be at a high risk for stroke, blood clots and deep vein ...